Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advertising of contrast material: a developing problem.

R L Siegle

    Radiology
    |October 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    New contrast agent advertising faces issues, leading to higher consumer costs for FDA testing. Unapproved uses persist due to lack of financial incentive, hindering medical advancements.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Changing roles: the radiologist in management.

    Academic radiology·1999
    Same author

    Radiology department management by radiologists.

    Academic radiology·1998
    Same author

    Rates of disagreement in imaging interpretation in a group of community hospitals.

    Academic radiology·1998
    Same author

    Comparison of iodixanol with iohexol in excretory urography.

    Academic radiology·1996
    Same author

    Substrate modification of melanin polymers to increase effectiveness of contrast agents for magnetic resonance imaging.

    Academic radiology·1996
    Same author

    Clinical research in a time of change.

    Academic radiology·1995
    Same journal

    Erratum for: Prediction of Lobar Emphysema Progression with a CT-Based Foundational Model.

    Radiology·2026
    Same journal

    Erratum for: Associations of MRI-derived Paraspinal IMAT and LMM with Cardiometabolic Risk Factors: Results from a German Cohort.

    Radiology·2026
    Same journal

    Erratum for: Blue Rubber Bleb Nevus Syndrome.

    Radiology·2026
    Same journal

    Redefining the Clinical Role of MRI in Endometrial Cancer Staging.

    Radiology·2026
    Same journal

    To Ablate or Not to Ablate: The Colorectal Liver Metastasis Question.

    Radiology·2026
    Same journal

    The Limits of Radiologic Categorization in Pulmonary Nonsolid Nodules.

    Radiology·2026
    See all related articles

    Area of Science:

    • Radiology
    • Medical Imaging
    • Pharmaceutical Advertising

    Background:

    • Current regulatory and advertising practices for medical contrast agents present significant challenges.
    • The financial incentives for seeking FDA approval for new and existing contrast agent indications are often misaligned with medical needs.

    Purpose of the Study:

    • To examine the problems associated with the advertising of new and existing contrast agents.
    • To highlight the financial and regulatory barriers affecting the approval of medically indicated uses for contrast agents.

    Main Methods:

    • Analysis of current regulatory pathways for contrast agent approval and advertising.
    • Examination of the economic factors influencing pharmaceutical companies' decisions regarding indication approval.

    Related Experiment Videos

    Main Results:

    • Consumers bear the cost of extensive FDA testing, which may not always be necessary.
    • Medically valuable uses of contrast agents may remain unapproved due to a lack of financial motivation for manufacturers.
    • Necessary updates to approved advertisements for contrast agents may be neglected for similar reasons.

    Conclusions:

    • A collaborative approach involving manufacturers, radiologists, and the FDA is essential to optimize the contrast agent approval and advertising process.
    • Addressing the financial disincentives is crucial for ensuring that all medically indicated uses of contrast agents are appropriately evaluated and approved.